Search

Search Constraints

You searched for: Author/Creator Cardiel, Mario H

Search Results

1. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Issue 10143 (21st July 2018)

2. Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort. (August 2020)

3. Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort. (August 2020)

4. First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR). Issue 11 (25th July 2018)

5. 199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study. (April 2019)

6. 289 Comparison of ACR 1982/1997 and EULAR/ACR classification criteria for systemic lupus erythematosus in two multiethnic cohorts. (April 2019)

7. CS-08 Effect of antimalarials over the different domains of the damage index in latin american SLE patients. (August 2018)

8. CE-19 Remission and low lupus disease activity status (LLDAS) protect lupus patients from damage occurrence: data from a multi-ethnic, multinational latin american lupus cohort. (31st August 2016)

9. CE-45 Baseline factors predictive of the occurrence of neuropsychiatric damage accrual in latin american patients with systemic lupus erythematosus. (31st August 2016)